| Christopher F Zielinski, DO | |
|
1741 Ne Douglas St Ste 200, Lees Summit, MO 64086-4704 | |
| (816) 246-0200 | |
| (913) 495-3730 |
| Full Name | Christopher F Zielinski |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1741 Ne Douglas St Ste 200, Lees Summit, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235132622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 05-37036 (Kansas) | Secondary |
| 207Q00000X | Family Medicine | 2018036669 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher F Zielinski, DO 8550 Marshall Dr Ste 220, Lenexa, KS 66214-1505 Ph: (816) 246-0200 | Christopher F Zielinski, DO 1741 Ne Douglas St Ste 200, Lees Summit, MO 64086-4704 Ph: (816) 246-0200 |
News Archive
In a Rose Garden speech, President Barack Obama said there was "no excuse" for the bungled rollout of the online health insurance marketplaces and promised that the difficulties would be ironed out.
The European Commission (EC) recently announced that it has adopted two new policy frameworks "to help developing countries address food security in emergency and long-term situations" and has called upon member nations to implement similar policies, IRIN reports.
Roark Capital Group, an Atlanta-based private equity firm, announced today that its affiliates have acquired Atkins Nutritionals, a leading international weight control and nutrition brand. Atkins' management team, led by CEO Monty Sharma, will remain with the business and invested alongside Roark Capital in the transaction. Terms of the transaction were not released.
Immune Design Corp. (IDC), a privately held biotechnology company developing novel vaccines and immunotherapies for infectious disease and cancer, announced today that it has entered into a license and development agreement with MedImmune for the use and commercialization of IDC's proprietary Glucopyranosyl Lipid Adjuvant (GLA) as a component in vaccines for select infectious diseases.
Scientists at the Johns Hopkins Kimmel Cancer Center and Duke University Medical Center have linked mutations in two genes, IDH1 and IDH2, to nearly three-quarters of several of the most common types of brain cancers known as gliomas.
› Verified 6 days ago
Dr. Valaree Rosann Smith, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2317 Ne Sweet Water Dr, Lees Summit, MO 64086 Phone: 816-525-7310 Fax: 816-525-7310 | |
Matthew Timothy Myrick, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Ne Saint Lukes Blvd, Lees Summit, MO 64086 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. John William Klema Iii, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4963 Ne Goodview Cir Ste B, Lees Summit, MO 64064 Phone: 816-795-7100 Fax: 816-795-7105 | |
Bradley Dean Chrisjohn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 Sw 3rd St, Lees Summit, MO 64063 Phone: 816-524-3799 Fax: 913-495-3727 | |
Matthew Cianciolo, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Ne Saint Lukes Blvd, Ste. 200, Lees Summit, MO 64086 Phone: 813-347-5100 Fax: 816-347-5136 | |
Crystal Brown-vredenburg, Family Medicine Medicare: Medicare Enrolled Practice Location: 20 Ne Saint Lukes Blvd Ste 200, Lees Summit, MO 64086 Phone: 816-347-5100 Fax: 816-347-5136 | |
Dr. Chad W Sharky, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 612 Sw 3rd St Ste D, Lees Summit, MO 64063 Phone: 816-355-5007 Fax: 208-845-6049 |